Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae

Vicki L. Collins, Dror Marchaim, Jason M. Pogue, Judy Moshos, Suchitha Bheemreddy, Bharath Sunkara, Alex Shallal, Neelu Chugh, Sara Eiseler, Pragati Bhargava, Christopher Blunden, Paul R. Lephart, Babar Irfan Memon, Kayoko Hayakawa, Odaliz Abreu-Lanfranco, Teena Chopra, L. Silvia Munoz-Price, Yehuda Carmeli, Keith S. Kaye

Research output: Contribution to journalArticle

38 Scopus citations

Abstract

Ertapenem is active against extended-spectrum-β-lactamase (ESBL)-producing Enterobacteriaceae organisms but inactive against Pseudomonas aeruginosa and Acinetobacter baumannii. Due to a lack of therapeutic data for ertapenem in the treatment of ESBL bloodstream infections (BSIs), group 2 carbapenems (e.g., imipenem or meropenem) are often preferred for treatment of ESBL-producing Enterobacteriaceae, although their antipseudomonal activity is unnecessary. From 2005 to 2010, 261 patients with ESBL BSIs were analyzed. Outcomes were equivalent between patients treated with ertapenem and those treated with group 2 carbapenems (mortality rates of 6% and 18%, respectively; P = 0.18).

Original languageEnglish (US)
Pages (from-to)2173-2177
Number of pages5
JournalAntimicrobial agents and chemotherapy
Volume56
Issue number4
DOIs
StatePublished - Apr 2012

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae'. Together they form a unique fingerprint.

  • Cite this

    Collins, V. L., Marchaim, D., Pogue, J. M., Moshos, J., Bheemreddy, S., Sunkara, B., Shallal, A., Chugh, N., Eiseler, S., Bhargava, P., Blunden, C., Lephart, P. R., Memon, B. I., Hayakawa, K., Abreu-Lanfranco, O., Chopra, T., Munoz-Price, L. S., Carmeli, Y., & Kaye, K. S. (2012). Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrobial agents and chemotherapy, 56(4), 2173-2177. https://doi.org/10.1128/AAC.05913-11